Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: A pilot randomized clinical trial

Journal of Clinical Psychiatry

Volumn 70, Issue 5, 2009, Pages 756-764

  Tramontina, Silzá ^a   Zeni, Cristian P ^a   Ketzer, Carla R ^a   Pheula, Gabriel F ^a   Narvaez, Joana ^a   Rohde, Luis Augusto ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PLACEBO;

ADOLESCENT; AKATHISIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BLURRED VISION; CHILD; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONFUSION; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; COUGHING; DECREASED APPETITE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRY SKIN; DYSKINESIA; DYSPNEA; ECCHYMOSIS; EDEMA; ENURESIS; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEMALE; HEADACHE; HOSTILITY; HUMAN; HYPERSALIVATION; INCREASED APPETITE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MEMORY DISORDER; MUSCLE CRAMP; MUSCLE RIGIDITY; NAUSEA; NECK INJURY; NERVOUSNESS; OCULOGYRIC CRISIS; OTALGIA; PARESTHESIA; PHOTOSENSITIVITY; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REFLEX DISORDER; RHINITIS; SCHOOL CHILD; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SWEATING; THORAX PAIN; THOUGHT DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; VOMITING; WALKING; WALKING DIFFICULTY; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CHILD; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; HUMANS; PILOT PROJECTS; PIPERAZINES; QUESTIONNAIRES; QUINOLONES;

EID: 67049137947     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04726     Document Type: Article

References (53)

1. Moreno C, Laje G, Blanco C, et al. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry. 2007;64(9):1032-1039. (Pubitemid 47360848)
2. McClellan J, Kowatch R, Findling RL. Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(1):107-125.
3. Perlis RH, Miyahara S, Marangell LB, et al, STEP-BD Investigators. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55(9):875-881. (Pubitemid 38526299)
4. Geller B, Luby J. Child and adolescent bipolar disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 1997;36(9):1168-1176. (Pubitemid 27381272)
5. Axelson D, Birmaher B, Strober M, et al. Phenomenology of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63(10):1139-1148. (Pubitemid 44498393)
6. Birmaher B, Axelson D. Course and outcome of bipolar spectrum disorder in children and adolescents: a review of the existing literature. Dev Psychopathol. 2006;18(4):1023-1035. (Pubitemid 46389728)
7. Birmaher B, Axelson D, Strober M, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63(2):175-183. (Pubitemid 43213879)
8. Tramontina S, Schmitz M, Polanczyk G, et al. Juvenile bipolar disorder in Brazil: clinical and treatment findings. Biol Psychiatry. 2003;53(11):1043- 1049. (Pubitemid 36645234)
9. Kowatch RA, Youngstrom EA, Danielyan A, et al. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disord. 2005;7(6):483-496. (Pubitemid 41829996)
10. Masi G, Perugi G, Millepiedi S, et al. Developmental differences according to age at onset in juvenile bipolar disorder. J Child Adolesc Psychopharmacol. 2006;16(6):679-685. (Pubitemid 46175424)
11. Strober M, DeAntonio M, Schmidt-Lackner S, et al. Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania. J Affect Disord. 1998;51(2):145-151. (Pubitemid 29101688)
12. Consoli A, Bouzamondo A, Guile JM, et al. Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a metaanalysis. Can J Psychiatry. 2007;52(5):323-328. (Pubitemid 46743461)
13. Kowatch RA, Fristad M, Birmaher B, et al. Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):213-235. (Pubitemid 40299835)
14. Pavuluri MN, Henry DB, Devineni B, et al. A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2004;43(7):859-867. (Pubitemid 38808491)
15. Cheng-Shannon J, McGough JJ, Pataki C, et al. Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol. 2004;14(3):372-394. (Pubitemid 39473123)
16. DelBello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1216-1223. (Pubitemid 38338041)
17. Tohen M, Kryzhanovskaya L, Carlson G, et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry. 2007;164(10):1547-1556. (Pubitemid 350069734)
18. Vieta E, Bourin M, Sanchez R, et al. Effectiveness of aripiprazole v haloperidol in acute bipolar mania: double-blind, randomized, comparative 12-week trial. Br J Psychiatry. 2005;187:235-242. (Pubitemid 41306104)
19. Keck PE Jr, Calabrese JR, McQuade RD, et al. A randomized, doubleblind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. J Clin Psychiatry. 2006;67(4):626-637. (Pubitemid 43764240)
20. Kessler RM. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism? Am J Psychiatry. 2007;164(9):1310-1312.
21. Biederman J, Mick E, Spencer T, et al. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr. 2007;12(9):683-689. (Pubitemid 47571968)
22. Tramontina S, Zeni CP, Pheula GF, et al. Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial. CNS Spectr. 2007;12(10):758-762. (Pubitemid 350072173)
23. Food and Drug Administration. Drug Approval Information, (http://www.fda.gov/cder/foi/label/2008/021436s21,021713s16,021729s8, 021866s8lbl.pdf). Accessed April 8, 2008.
24. Chang K, et al. Efficacy of aripiprazole in children (10-17) years old with mania. In: Abstracts of the Annual Meeting of the American Academy of Child and Adolescent Psychiatry; October 23-28, 2007;Boston, MA. Abstract B6.
25. Sismondo S. Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials. 2008;29(2):109-113. (Pubitemid 351248768)
26. American Diabetes Association & American Psychiatric Association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601. (Pubitemid 38180442)
27. Correll CU. Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. J Am Acad Child Adolesc Psychiatry. 2007;46(6):687-700. (Pubitemid 46816822)
28. Tramontina S, Zeni CP, Pheula G, et al. Topiramate in adolescents with juvenile bipolar disorder presenting weight gain due to atypical antipsychotics or mood stabilizers: an open clinical trial. J Child Adolesc Psychopharmacol. 2007;17(1):129-134. (Pubitemid 46452089)
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
30. Findling RL, McNamara NK, Stansbrey R, et al. Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J Am Acad Child Adolesc Psychiatry. 2006;45(2):142-148. (Pubitemid 43151518)
31. Biederman J, Mick E, Spencer T, et al. A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord. 2007;9(8):888-894. (Pubitemid 350215115)
32. Wechsler D. WISC-III Manual. New York, NY: The Psychological Corporation; 1991.
33. Orvaschel H. Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bull. 1985;21(4):737-745. (Pubitemid 16177278)
34. Polanczyk GV, Eizirik M, Aranovich V, et al. Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E). Rev Bras Psiquiatr. 2003;25(2):87-90. (Pubitemid 36995302)
35. Youngstrom EA, Danielson CK, Findling RL, et al. Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years. J Clin Child Adolesc Psychol. 2002;31(4):567-572. (Pubitemid 37110241)
36. A 14-month randomized clinical trial of treatment strategies for attentiondeficit/ hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry. 1999;56(12):1073- 1086.
37. Vilela JAA. Loureiro SR. Escala de Avaliação de Mania de Young: estudo das qualidades psicométricas da versão brasileira. In: Gorenstein C, Andrade L. Zuardi A, eds. Escalas de Avaliação Clínica em Psiquiatria e Psicofarmacologia. São Paulo, Brazil: Lemos Editorial, 2000.113-123
38. Mattos P, Serra-Pinheiro M, Rohde L, et al. Apresentação de uma versão em português para uso no Brasil do instrumento MTA-SNAP-IV de avaliação de sintomas de transtorno do déficit de atenção/hiperatividade e sintomas de transtorno desafiador e de oposição. Rev Psiquiatr RS. 2006;28:290-297. (Pubitemid 46569763)
39. Pavuluri MN, Henry DB, Devineni B, et al. Child mania rating scale: development, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 2006;45(5):550-560. (Pubitemid 43756184)
40. Guy W. Clinical Global Impressions (CGI) Scale. In: Rush AJ, First MB, Blacker D, eds. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Publishing; 2000.
41. Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics. 1979;64(4):442-450. (Pubitemid 9247602)
42. Barbosa GA, Dias MD, Gaião AA, et al. Escala para avaliação de depressão em crianças - revisada (CDRS-R): uma análise exploratória. Infanto. 1997;1:15-18.
43. Brooks SJ, Krulewicz SP, Kutcher S. The Kutcher Adolescent Depression Scale: assessment of its evaluative properties over the course of an 8-week pediatric pharmacotherapy trial. J Child Adolesc Psychopharmacol. 2003;13(3):337-349. (Pubitemid 37288534)
44. Greenhill LL, Vitiello B, Fisher P, et al. Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology. J Am Acad Child Adolesc Psychiatry. 2004;43(12):1488-1496. (Pubitemid 40468623)
45. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923-936. (Pubitemid 24002359)
46. Altman DG. Practical Statistics for Medical Research. London, UK: Chapman & Hall; 1991.
47. Leibenluft E, Charney DS, Towbin KE, et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatry. 2003;160(3):430-437. (Pubitemid 41094250)
48. Galanter CA, Leibenluft E. Frontiers between attention deficit hyperactivity disorder and bipolar disorder. Child Adolesc Psychiatr Clin N Am. 2008;17(2):325-346. (Pubitemid 351258352)
49. Barzman DH, DelBello MP, Kowatch RA, et al. The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review. J Child Adolesc Psychopharmacol. 2004;14(4):593-600.
50. Biederman J, McDonnell MA, Wozniak J, et al. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr. 2005;10(2):141-148. (Pubitemid 40327779)
51. Gibson AP, Crismon ML, Mican LM, et al. Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation. Int Clin Psychopharmacol. 2007;22(2):101-105. (Pubitemid 46254870)
52. Soutullo CA, Chang KD, Díez-Suárez A, et al. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology. Bipolar Disord. 2005;7(6):497-506. (Pubitemid 41829997)
53. Scales DC, Adhikari KJ. Maintaining allocation concealment: following your SNOSE. J Crit Care. 2005;20(2):191-193. (Pubitemid 41219644)